NO954390D0 - Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner - Google Patents

Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner

Info

Publication number
NO954390D0
NO954390D0 NO954390A NO954390A NO954390D0 NO 954390 D0 NO954390 D0 NO 954390D0 NO 954390 A NO954390 A NO 954390A NO 954390 A NO954390 A NO 954390A NO 954390 D0 NO954390 D0 NO 954390D0
Authority
NO
Norway
Prior art keywords
acyclovir
combating
herpes simplex
simplex virus
virus infections
Prior art date
Application number
NO954390A
Other languages
English (en)
Other versions
NO954390L (no
Inventor
James Gus Chafouleas
Robert Deziel
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of NO954390D0 publication Critical patent/NO954390D0/no
Publication of NO954390L publication Critical patent/NO954390L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO954390A 1993-05-03 1995-11-02 Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner NO954390L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002095408A CA2095408A1 (en) 1993-05-03 1993-05-03 Method of combating acyclovir-resistant herpes simplex viral infections
PCT/CA1994/000242 WO1994025046A1 (en) 1993-05-03 1994-04-29 Method of combating acyclovir-resistant herpes simplex viral infections

Publications (2)

Publication Number Publication Date
NO954390D0 true NO954390D0 (no) 1995-11-02
NO954390L NO954390L (no) 1996-01-02

Family

ID=4151571

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954390A NO954390L (no) 1993-05-03 1995-11-02 Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner

Country Status (13)

Country Link
EP (1) EP0767671A1 (no)
JP (1) JPH08509476A (no)
KR (1) KR960701651A (no)
CN (1) CN1126438A (no)
AU (1) AU683465B2 (no)
BR (1) BR9406575A (no)
CA (1) CA2095408A1 (no)
CZ (1) CZ287795A3 (no)
HU (1) HUT73779A (no)
NO (1) NO954390L (no)
SG (1) SG48806A1 (no)
SK (1) SK132695A3 (no)
WO (1) WO1994025046A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
CA2139169C (en) * 1994-12-28 2001-05-01 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes peptidomimetic compounds
CN109627243B (zh) * 2019-01-09 2021-06-29 广西壮族自治区水产科学研究院 一种喷昔洛韦-铜配合物、合成方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
EP0560267B1 (en) * 1992-03-12 1998-08-19 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives

Also Published As

Publication number Publication date
KR960701651A (ko) 1996-03-28
BR9406575A (pt) 1996-03-19
AU6642394A (en) 1994-11-21
SG48806A1 (en) 1998-05-18
HUT73779A (en) 1996-09-30
CZ287795A3 (en) 1996-06-12
JPH08509476A (ja) 1996-10-08
NO954390L (no) 1996-01-02
AU683465B2 (en) 1997-11-13
CN1126438A (zh) 1996-07-10
CA2095408A1 (en) 1994-11-04
HU9503135D0 (en) 1996-01-29
WO1994025046A1 (en) 1994-11-10
SK132695A3 (en) 1996-10-02
EP0767671A1 (en) 1997-04-16

Similar Documents

Publication Publication Date Title
DK42093D0 (da) Administrationsmetode
FI930657A (fi) Foerfarande foer framstaellning av doseringsformer med foerlaengd aktivaemnesfrigivning
FI951986A0 (fi) Aallonpituusspesifiset valoherkät porfasyaniini- ja laajennetut porfyriinin kaltaiset yhdisteet ja niiden valmistusmenetelmät ja käyttö
GB9709360D0 (en) Methods for the treatment of herpes virus infections
FI955458A0 (fi) Uudelleenkastumisen estävä kate puristusrullia varten
AU3717693A (en) Method of treating and preventing viral infections using HBNF and MK protein
NO940810D0 (no) Behandling av virusinfeksjoner
KR950702191A (ko) 신규의 벤조디아제핀 유도체(Novel Benzodiazepine derivative)
NO954390D0 (no) Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner
EP0794781A4 (en) PREVENTIVE MEDICINES FOR RECURRING HERPES VIRUS INFECTIONS
LV10191A (lv) Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai
EP0526652A4 (en) Method of type-specific detection of herpes simplex virus
AU2591692A (en) Method of treating latent herpes viral infections
AU9079491A (en) Combinations of vanilloid compounds and phosphonate antiviral compounds for treatment of herpes infections
FI965114A0 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
IL110511A0 (en) Topical pharmaceutical formulation for treating viral infections
NO972688D0 (no) Anvendelse av aminopurin-antivirale-midler for behandling og profylakse av latente herpesvirus-infeksjoner
GB9419692D0 (en) Treatment of herpes infections
AU2414992A (en) Method of combatting hiv infections
FI930237A (fi) Foerfarande foer framstaellning av 4,6-dialkoxipyrimidiner
AU5960794A (en) Compositions effective against acyclovir-resistant strains of herpes viruses
MX9201540A (es) Derivados de amidina y proceso para su preparacion.
AU4611093A (en) Method of treating viral infections
NO933622D0 (no) Benzendimetanol som er egnet for mikronisering
ES1020264Y (es) Conjunto de perfiles para sujecion de laminas.